Iodine repletion, thyrotoxicosis and atrial fibrillation in Isfahan, Iran

Annals of Saudi Medicine

Volumn 24, Issue 1, 2004, Pages 13-17

  Aminorroaya, Ashraf ^a   Rohani, Sina ^a   Sattari, Goshtasb ^a   Haghighi, Sasan ^a   Amini, Masoud ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atrial fibrillation; Hyperthyroidism; Iodine repletion; Iran; Thyrotoxicosis

Indexed keywords

IODINE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; FEMALE; HASHIMOTO DISEASE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINATION; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALT INTAKE; TEACHING HOSPITAL; THYROID FUNCTION; THYROID FUNCTION TEST; THYROTOXICOSIS; TOXIC GOITER; UNIVERSITY HOSPITAL;

EID: 1042280963     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2004.13     Document Type: Article

References (35)

1. Kastor JA. Atrial fibrillation. In: Kastor, JA, ed. Kastors' arrhythmias. Philadelphia: WB Saunders; 1994: 25-104.
2. Zonszein J, Sonnenblick EH. Endocrine disease and the cardiovascular system. In: Alexander RW, Schlant RC, Fuster U, O' Rouke RA, Roberts R, Sonneriblick EH, eds. Hurst's the heart. New York: MC Graw Hill; 1998: 2117-2142.
3. Ladenson PW. Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med. 1990; 88(6):638-641.
4. Kerr C, Boone J, Connolly S, Greene M, Klein G, Sheldon R, et al. Follow up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation. Eur Heart J. 1996; 17 suppl C: 48-51.
5. Davidson E, Weinberyger I, Rotenberg Z, Fuchs J. Agmon J. Atrial fibrillation: cause and time of onset. Arch Intern Med. 1989; 149 (2): 457-469.
6. Fagerberg B, Lindstedt G, Stromblad So, Darpo B, Nystrom E, Sjostrom L, et al. Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition? Clin Chem. 1990; 36(4): 620-627.
7. Qvist P, Vejby-Christensen H. Thyrotoxicosis in patients hospitalized because of atrial fibrillation. Ugeskr Laeger. 1989; 151 (37): 2373-2374.
8. Schlicnger JL, Cherfan J, Drawin T, Sacrez A. Systematic ultrasensitive determination of thyroid stimulating hormone in 50 cases of atrial fibrillation. Presse Med. 1988; 17(16): 787-790.
9. Haslett C, Douglas JG, Munro JF. Rheumatic heart disease and thyroid status. Scott Med J. 1988; 28(1): 17-20.
10. Inama G, Furlanello F, Fiorentini F, Braito G, Vergara G, Casana P. Arrhythmogenic implications of non-iatrogenic thyroid dysfunction. G Ital Cardiol. 1989; 19(4): 303-310.
11. Barnes DJ, O'Connor JD, Bending JJ. Hypothyroidism in the elderly: clinical assessment versus routine screening. Br J Clin Pract. 1993; 47(3):123-127.
12. Azizi F, Kimiagar M, Nafarabadi M, Mostafavi H. Goiter in Tehran and suburbs. In: Vichayanart A et al., eds. Recent progress in thyroidology. Proceedings of the Third Asia & Oceania Thyroid Association; 1986 Dec 4-6: 388-391.
13. Kimiagar M, Yassai MB, Nafarabadi M, Azizi F. Endemic goiter in Boyer-Ahmad. Med J IRI. 1989; 3: 27-29.
14. Kimiagar M, Azizi F, Navai L, Yassai M. Survey of iodine deficiency in a rural area near Tehran : Association of food intake and endemic goiter. Europ J Nutr. 1990; 44: 17-22.
15. IDD activities in IRAN. Iodine Deficiency Disorders. Monitoring and Evaluation. Middle East and Eastern Mediterranean region. Available from: URL: http://www.erc-iran.com/idd/iran%20&%20idd.htm. (accessed in 2002).
16. Azizi F, Mirmiran P, Sheikholeslam R, Hedayati M, Rastmanesh R. The relation between serum ferritin and goiter, urinary iodine and thyroid hormone concentration. Int J Vitam Nutr Res. 2002 ;75(5): 296-299.
17. Aminorroaya A, Amini M, Rezvanian H, Kachoie A, Sadri Gh, Mirdamadi M, et al. Effects of iodized salt consumption on goiter prevalence in Isfahan:The possible role of goitrogens. Endocr Pract. 2001; 7 (2): 95-98.
18. Aminorroaya A, Amini M. Salehi I. Thyroid function in atrial fibrillation. Med J IR. 1997; 11 (1)(5): 45.
19. Vagenakis AG, Roti E. Effects of excess iodide, clinical aspects. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid, a fundamental and clinical text. Philadelphia: Lippincott Raven; 1996: 316-327.
20. Wartofsky L. Diseases of the thyroid. In: Fauci AS, Branwaled E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al., eds. Harrison's principles of internal medicine. New York: Mc Graw Hill; 1998: 2012-2034.
21. Dillmann WH. The thyroid. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine. Philadelphia: WB Saunders; 1996: 1227-1244.
22. Smallridge RC. Thyroid function tests. In: Becker KL, Bilezikian JP, Bermner WJ, Hung W, Kahn CR, Loraux DL, et al., eds. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott Raven; 1995: 299-306.
23. Burch HB. Abnormal thyroid function test results in euthyroid persons. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott Raven; 1995: 323-332.
24. Cavalieri RP, Pitt Rivers R. The effects of drugs on the distribution and metabolism of thyroid hormones. Pharmacol Rev. 1981; 33(2): 55-80.
25. Larsen PR. Davies TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. William's textbook of endocrinology. Philadelphia: WB Saunders; 1998: 389-515.
26. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major contributes to stroke in the elderly. The Framingham study. Arch Intern Med. 1987; 147: 1561-1564.
27. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994; 331 (19): 1249-1252.
28. De Carvalho Filho ET, Miotta ST, Alves AT, Curiati JA, De Alencar YM. Chronic atrial fibrillation in the elderly. Arq Bras Cardiol. 1991; 57(2): 109-114.
29. Casiglia E, Maschio O, Spolaore P, Colangeli G, Celegon L, Gozzetti S, et al. Atrial fibrillation in a cohort study in the elderly: etipathogenic role of occult hyperthyroidism and diagnostic and therapeutic considerations. Results of the CASTEL (cardiovascular study in the elderly). Cardiologia. 1991; 36(9): 685-691.
30. Dunn JT, Semigran MJ, Delange F. The prevention and management of iodine - induced hyperthyroidism and its cardiac features. Thyroid. 1998; 8(1): 101-106.
31. Boukis MA, Koutras DA, Souvatzoglou A. Evangelopoulou A, Vrontakis M, Moulopoulos SD. Thyroid hormone and immunologic studies in endemic goiter. J Clin Endocrinol Metab. 1983; 57(4), 857-862.
32. Forfar JC, Toft AD. Thyrotoxic atrial fibrillation, an underdiagnosed condition? Br Med J. 1982; 285: 909-910.
33. Nordyke RA, Gilbert H, Harda AS. Graves disease. Influence of age on clinical findings. Arch Intern Med. 1988; 148(3): 626-631.
34. Trivalle C, Doucet J, Chassagne P, Landrin I, Kadri N, Menard JF, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996; 44(1): 50-53.
35. Martin FL, Deam DR. Hyperthyroidism in elderly hospitalized patients. Clinical features and treatment outcomes. Med J Aust. 1996; 19; 164(4): 200-203.